1.
García-Vázquez E, Marcos MA, Mensa J, et al. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch Intern Med. 2004;164(16):1807-1811. doi:10.1001/ARCHINTE.164.16.1807
2.
Derbyshire EJ, Calder PC. Respiratory tract ınfections and antibiotic resistance: a protective role for vitamin D? Front Nutr. 2021;8:652469. doi:10.3389/FNUT.2021.652469/BIBTEX
3.
Pailhoriès H, Herrmann JL, Velo-Suarez L, et al. Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome. Eur Respir Rev. 2022;31(164):210259. doi:10.1183/16000617.0259-2021
4.
Guitor AK, Wright GD. Antimicrobial resistance and respiratory ınfections. Chest. 2018;154(5):1202-1212. doi:10.1016/J.CHEST.2018.06. 019
5.
Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and ınfectious diseases society of America.Am J Respir Crit Care Med. 2019;200(7):e45-e67. doi: 10.1164/rccm.201908-1581ST
6.
Zhao J, Schloss PD, Kalikin LM, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A. 2012;109(15):5809-5814. doi:10.1073/PNAS.1120577109/SUPPL_FILE/PNAS.201120577SI.PDF
7.
Savanur SS, Gururaj H. Study of antibiotic sensitivity and resistance pattern of bacterial ısolates in ıntensive care unit setup of a tertiary care hospital ndian J Crit Care Med. 2019;23(12):547-555. doi:10.5005/jp-journals-10071-23295
8.
Al-Sunaidar KA, Aziz NA, Hassan Y, Jamshed S, Sekar M. Association of multidrug resistance bacteria and clinical outcomes of adult patients with sepsis in the ıntensive care unit. Trop Med Infect Dis. 2022;7(11):365. doi:10.3390/tropicalmed7110365
9.
Martin-Loeches I, Torres A, Nagavci B, et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Eur Respir J. 2023;61(4):2200735. doi:10.1183/13993003. 00735-2022
10.
Restrepo MI, Babu BL, Reyes LF, et al. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J. 2018;52(2):1701190. doi:10.1183/13993003.01190-2017
11.
Tacconelli E. New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission. Clin Microbiol Infect. 2006;12(2): 102-109. doi:10.1111/j.1469-0691.2005.01326.x
12.
Chi? AA, Rus LL, Morgovan C, et al. Microbial resistance to antibiotics and effective antibiotherapy. Biomedicines. 2022;10(5):1121. doi:10.3390/biomedicines10051121
13.
MacFadden DR, Coburn B, Shah N, et al. Utility of prior cultures in predicting antibiotic resistance of bloodstream infections due to gram-negative pathogens: a multicentre observational cohort study. Clin Microbiol Infect. 2018;24(5):493-499. doi:10.1016/j.cmi.2017.07.032
14.
Holm M, Zellweger RM, Poudyal N, Smith KH, Joh HS, Marks F. Measuring the link between vaccines and antimicrobial resistance in low resource settings - limitations and opportunities in direct and ındirect assessments and ımplications for ımpact studies. Front Trop Dis. 2022;3:805833. doi:10.3389/fitd.2022.805833
15.
Mishra RP, Oviedo-Orta E, Prachi P, Rappuoli R, Bagnoli F. Vaccines and antibiotic resistance. Curr Opin Microbiol. 2012;15(5):596-602. doi: 10.1016/j.mib.2012.08.002
16.
Kuster SP, Rudnick W, Shigayeva A, et al. Previous antibiotic exposure and antimicrobial resistance in ınvasive pneumococcal disease: results from prospective surveillance. Clin Infect Dis. 2014;59(7):944-952. doi: 10.1093/cid/ciu497